Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγnull (NOG) mice

Yoko Matsuda, Hisashi Yoshimura, Junji Ueda, Zenya Naito, Murray Korc, Toshiyuki Ishiwata

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is associated with a high incidence of hepatic metastases, as well as occasional pulmonary metastases. To delineate the potential role of cancer stem cells (CSCs) in PDAC metastasis, human PDAC cells were injected into the spleen of mice. The characteristics and expression of markers associated with CSC and epithelial-mesenchymal transition (EMT) of metastatic cells that developed in the liver and lung were then compared with parental cells. The metastatic cells were polygonal, and larger than parental cells. Metastatic cells also exhibited decreased proliferation and increased adhesion to extracellular matrices, as well as enhanced migration and invasion in vitro and increased metastatic capacity in vivo. The CSC markers ALDH1A1, ABCG2, and nestin were expressed at high levels in metastatic cells and exhibited changes consistent with EMT (eg, decreased E-cadherin expression). Moreover, metastatic cells readily formed spheres in culture and exhibited an increased side population by flow analysis. Nestin and ABCG2 were also expressed at high levels in metastatic lesions from PDAC patients, and silencing nestin with shRNA in PDAC cells derived from lung metastases resulted in a marked decrease in the capacity of the cells to form spheres and to yield pulmonary or hepatic metastases. Thus, the metastatic potential of human PDAC cells correlates with CSCs and with EMT characteristics and is dependent on nestin expression.

Original languageEnglish
Pages (from-to)674-685
Number of pages12
JournalAmerican Journal of Pathology
Volume184
Issue number3
DOIs
StatePublished - Mar 2014

Fingerprint

Nestin
Neoplastic Stem Cells
Pancreatic Neoplasms
Adenocarcinoma
Epithelial-Mesenchymal Transition
Neoplasm Metastasis
Lung
Liver
Cadherins
Small Interfering RNA
Extracellular Matrix
Spleen

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγnull (NOG) mice. / Matsuda, Yoko; Yoshimura, Hisashi; Ueda, Junji; Naito, Zenya; Korc, Murray; Ishiwata, Toshiyuki.

In: American Journal of Pathology, Vol. 184, No. 3, 03.2014, p. 674-685.

Research output: Contribution to journalArticle

Matsuda, Yoko ; Yoshimura, Hisashi ; Ueda, Junji ; Naito, Zenya ; Korc, Murray ; Ishiwata, Toshiyuki. / Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγnull (NOG) mice. In: American Journal of Pathology. 2014 ; Vol. 184, No. 3. pp. 674-685.
@article{8df9429449c84c19a154d89f2ac490be,
title = "Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγnull (NOG) mice",
abstract = "Pancreatic ductal adenocarcinoma (PDAC) is associated with a high incidence of hepatic metastases, as well as occasional pulmonary metastases. To delineate the potential role of cancer stem cells (CSCs) in PDAC metastasis, human PDAC cells were injected into the spleen of mice. The characteristics and expression of markers associated with CSC and epithelial-mesenchymal transition (EMT) of metastatic cells that developed in the liver and lung were then compared with parental cells. The metastatic cells were polygonal, and larger than parental cells. Metastatic cells also exhibited decreased proliferation and increased adhesion to extracellular matrices, as well as enhanced migration and invasion in vitro and increased metastatic capacity in vivo. The CSC markers ALDH1A1, ABCG2, and nestin were expressed at high levels in metastatic cells and exhibited changes consistent with EMT (eg, decreased E-cadherin expression). Moreover, metastatic cells readily formed spheres in culture and exhibited an increased side population by flow analysis. Nestin and ABCG2 were also expressed at high levels in metastatic lesions from PDAC patients, and silencing nestin with shRNA in PDAC cells derived from lung metastases resulted in a marked decrease in the capacity of the cells to form spheres and to yield pulmonary or hepatic metastases. Thus, the metastatic potential of human PDAC cells correlates with CSCs and with EMT characteristics and is dependent on nestin expression.",
author = "Yoko Matsuda and Hisashi Yoshimura and Junji Ueda and Zenya Naito and Murray Korc and Toshiyuki Ishiwata",
year = "2014",
month = "3",
doi = "10.1016/j.ajpath.2013.11.014",
language = "English",
volume = "184",
pages = "674--685",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγnull (NOG) mice

AU - Matsuda, Yoko

AU - Yoshimura, Hisashi

AU - Ueda, Junji

AU - Naito, Zenya

AU - Korc, Murray

AU - Ishiwata, Toshiyuki

PY - 2014/3

Y1 - 2014/3

N2 - Pancreatic ductal adenocarcinoma (PDAC) is associated with a high incidence of hepatic metastases, as well as occasional pulmonary metastases. To delineate the potential role of cancer stem cells (CSCs) in PDAC metastasis, human PDAC cells were injected into the spleen of mice. The characteristics and expression of markers associated with CSC and epithelial-mesenchymal transition (EMT) of metastatic cells that developed in the liver and lung were then compared with parental cells. The metastatic cells were polygonal, and larger than parental cells. Metastatic cells also exhibited decreased proliferation and increased adhesion to extracellular matrices, as well as enhanced migration and invasion in vitro and increased metastatic capacity in vivo. The CSC markers ALDH1A1, ABCG2, and nestin were expressed at high levels in metastatic cells and exhibited changes consistent with EMT (eg, decreased E-cadherin expression). Moreover, metastatic cells readily formed spheres in culture and exhibited an increased side population by flow analysis. Nestin and ABCG2 were also expressed at high levels in metastatic lesions from PDAC patients, and silencing nestin with shRNA in PDAC cells derived from lung metastases resulted in a marked decrease in the capacity of the cells to form spheres and to yield pulmonary or hepatic metastases. Thus, the metastatic potential of human PDAC cells correlates with CSCs and with EMT characteristics and is dependent on nestin expression.

AB - Pancreatic ductal adenocarcinoma (PDAC) is associated with a high incidence of hepatic metastases, as well as occasional pulmonary metastases. To delineate the potential role of cancer stem cells (CSCs) in PDAC metastasis, human PDAC cells were injected into the spleen of mice. The characteristics and expression of markers associated with CSC and epithelial-mesenchymal transition (EMT) of metastatic cells that developed in the liver and lung were then compared with parental cells. The metastatic cells were polygonal, and larger than parental cells. Metastatic cells also exhibited decreased proliferation and increased adhesion to extracellular matrices, as well as enhanced migration and invasion in vitro and increased metastatic capacity in vivo. The CSC markers ALDH1A1, ABCG2, and nestin were expressed at high levels in metastatic cells and exhibited changes consistent with EMT (eg, decreased E-cadherin expression). Moreover, metastatic cells readily formed spheres in culture and exhibited an increased side population by flow analysis. Nestin and ABCG2 were also expressed at high levels in metastatic lesions from PDAC patients, and silencing nestin with shRNA in PDAC cells derived from lung metastases resulted in a marked decrease in the capacity of the cells to form spheres and to yield pulmonary or hepatic metastases. Thus, the metastatic potential of human PDAC cells correlates with CSCs and with EMT characteristics and is dependent on nestin expression.

UR - http://www.scopus.com/inward/record.url?scp=84894110505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894110505&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2013.11.014

DO - 10.1016/j.ajpath.2013.11.014

M3 - Article

C2 - 24412093

AN - SCOPUS:84894110505

VL - 184

SP - 674

EP - 685

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 3

ER -